Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The mechanism of action of Mounjaro (Tirzepatide) involves its active ingredient, Tirzepatide, which can simultaneously act on both GIP and GLP-1 intestinal hormone receptors, resulting in multiple metabolic benefits: This medication, by activating both the GIP and GLP-1 receptors, not only stimulates insulin secretion but also helps regulate appetite, reduce food intake, and enhance satiety, providing a comprehensive approach to weight control
Patients receive care from providers who specialize in menopause medicine and understand how fluctuating estrogen, progesterone, and other hormones directly affect metabolism, weight distribution, and GLP-1 medication response
A 2025 review showed that 35 preclinical trials and one clinical study have been completed with BPC-157.[ref] Lets take a look at how this plays out in specific injuries and wounds
The product has generated serious buzz in the gut health and peptide and GLP-1 research community
CarterSepio CapitalSalt Lake CityUtah$10M$4.6B$10-250M$10-100MCharles ParryWells Fargo AdvisorsSalt Lake CityUtah$1M$2.2B$250K-50M$1-30MJeffry RoundyMerrill Wealth ManagementSalt Lake CityUtah$10M$2B$10-200M$10-150MDane RuniaMorgan Stanley Private Wealth ManagementProvoUtah$10M$2.1B$10-100M$10-100MZach BurtonNorthwestern MutualFarmingtonUtah$250K$505M$1-20M$500K-60MPaul ShoemakerMorgan Stanley Wealth ManagementSalt Lake CityUtah$2M$2.5B$7.5-50M$3-150MMark PyperUtah Wealth Management Group | Wells Fargo AdvisorsSalt Lake CityUtah$500K$900M$2-10M$1-8MStacey FredricksonAmeriprise Financial ServicesClearfieldUtah$350K$1B$1.5-10M$250K-2MScott HullingerMerrill Wealth ManagementProvoUtah$1M$1.2B$2.5-10M$1-5MNeil HullingerMerrill Wealth ManagementProvoUtah$1M$1.2B$2.5-10M$1-7.5MChris N
For straightforward cases where the patient meets standard eligibility criteria, e-consults are usually sufficient
